Immuno-Oncology Drug Market

Global Immuno-Oncology Drugs Market Outlook, Opportunities And Strategies

Learn about the global immuno-oncology drugs market through The Business Research Company, which provides information on immuno-oncology drugs market size, immuno-oncology drugs market drivers and restraints, immuno-oncology drugs market players, the COVID-19 impact on the immuno-oncology drugs market, and more.

Our annual holiday sale is here! Get your discounted market research reports today.

The global immuno-oncology drugs market is expected to grow from $57.28 billion in 2020 to $62.99 billion in 2021 at a compound annual growth rate (CAGR) of 10%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The immuno-oncology drugs market is expected to reach $92.97 billion in 2025 at a CAGR of 10%.

The rise in the number of cancer cases across the globe is expected to drive innovation in immuno-oncology drugs manufacturing, thus driving the market during the forecast period.

Request A Sample For The Global Immuno-Oncology Drugs Market Report:

The immuno-oncology drugs market consists of sales of immuno-oncology drugs used for the treatment of cancer and related services by entities (organizations, sole traders and partnerships) that produce immuno-oncology drugs for cancer treatment. Immuno-oncology is the artificial stimulation of the immune system to treat cancer, improving the immune system’s ability to fight the disease. The market consists of revenue generated by the companies manufacturing immuno-oncology drugs by the sales of these products.

Global immuno-oncology drugs market segments include:

By Type: Monoclonal Antibodies, Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines, Others

By Therapeutic Application: Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Prostate Cancer, Bladder Cancer, Others

By End-User: Hospitals, Clinics, Ambulatory Surgical Centres, Cancer Research Institutes

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Companies in the immuno-oncology drugs market are increasing their product innovation through strategic collaborations. To sustain in the increasingly competitive immuno-oncology drugs market, companies are developing innovative products as well as sharing skills and expertise with other companies. While companies have long collaborated with each other as well as with academic and research institutions in this market by way of partnerships, and in- or out-licensing deals, this trend has been increasing over the recent years.

TBRC’s immuno-oncology drugs market report covers:

Major Market Players: Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Merck & Co., F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis International AG, and AbbVie Inc.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Immuno-Oncology Drugs Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides immuno-oncology drugs market overviews, analyzes and forecasts market size, share, immuno-oncology drugs market players, immuno-oncology drugs market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s immuno-oncology drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here is a list of similar reports from The Business Research Company:

Clinical Oncology Next Generation Sequencing Global Market Report 2021

Cancer Clinical Decision Tools Global Market Report 2021

Cancer Diagnostics Global Market Report 2021

Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293


Follow us on LinkedIn:

Follow us on Twitter:

Check out our Blog:

Check out our Global Market Model:

Leave a Reply

Your email address will not be published. Required fields are marked *